PW Medtech Group Ltd. (1358) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Modern Dental Group Ltd.

PW Medtech Group Ltd.

Shanghai INT Medical Instruments Co., Ltd.

Essex Bio-Technology Ltd.

Zylox-Tonbridge Medical Technology Co., Ltd.

Sisram Medical Ltd.

Acotec Scientific Holdings Ltd.

Shanghai Conant Optical Co., Ltd.

MicroPort CardioFlow Medtech Corp.

Peijia Medical Ltd.

Venus Medtech (Hangzhou), Inc.

Why is PW Medtech Group Ltd. ?

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 69.46

Healthy long term growth as Net Sales has grown by an annual rate of 23.04%

Negative results in Jun 25

INTEREST(HY) At HKD 0.35 MM has Grown at 175.54%
INTEREST COVERAGE RATIO(Q) Lowest at 40,874.7
RAW MATERIAL COST(Y) Grown by 7.48% (YoY)

With ROE of 4.97%, it has a Attractive valuation with a 0.52 Price to Book Value

Over the past year, while the stock has generated a return of 0.93%, its profits have fallen by -7.4%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to PW Medtech Group Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is PW Medtech Group Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

PW Medtech Group Ltd.

-100.0%

0.03

37.01%

Hang Seng Hong Kong

8.25%

0.41

19.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

23.04%

EBIT Growth (5y)

42.60%

EBIT to Interest (avg)

69.46

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.42

Sales to Capital Employed (avg)

0.13

Tax Ratio

16.20%

Dividend Payout Ratio

92.54%

Pledged Shares

Institutional Holding

ROCE (avg)

2.88%

ROE (avg)

8.97%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.52

EV to EBIT

2.89

EV to EBITDA

1.54

EV to Capital Employed

0.17

EV to Sales

0.50

PEG Ratio

Dividend Yield

1.42%

ROCE (Latest)

5.96%

ROE (Latest)

4.97%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

OPERATING CASH FLOW(Y)

Highest at HKD 702.4 MM

CASH AND EQV(HY)

Highest at HKD 1,948.39 MM

DEBT-EQUITY RATIO (HY)

Lowest at -43.95 %

INVENTORY TURNOVER RATIO(HY)

Highest at 2.9 times

-11What is not working for the Company

INTEREST(HY)

At HKD 0.35 MM has Grown at 175.54%

INTEREST COVERAGE RATIO(Q)

Lowest at 40,874.7

RAW MATERIAL COST(Y)

Grown by 7.48% (YoY

PRE-TAX PROFIT(Q)

Lowest at HKD 111.51 MM

NET PROFIT(Q)

Lowest at HKD 71.51 MM

EPS(Q)

Lowest at HKD 0.05

Here's what is working for PW Medtech Group Ltd.

Operating Cash Flow

Highest at HKD 702.4 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Cash and Eqv

Highest at HKD 1,948.39 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -43.95 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio

Highest at 2.9 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Depreciation

Highest at HKD 73.46 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Here's what is not working for PW Medtech Group Ltd.

Interest

At HKD 0.35 MM has Grown at 175.54%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Interest Coverage Ratio

Lowest at 40,874.7 and Fallen

In each period in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit

Lowest at HKD 111.51 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit

Lowest at HKD 71.51 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (HKD MM)

EPS

Lowest at HKD 0.05

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (HKD)

Raw Material Cost

Grown by 7.48% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales